Evidence mapPaperPMID 31340611Full record

Trial reportNutrients2019

Postprandial Effects of a Proprietary Milk Protein Hydrolysate Containing Bioactive Peptides in Prediabetic Subjects.

Tina Sartorius, Andrea Weidner, Tanita Dharsono, Audrey Boulier, Manfred Wilhelm, Christiane Schön

Erratum issuedOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Advancements inFood chemistry: X · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Nutritional strategies to attenuate postprandial glycemic response.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2022
    Review
  16. Conventional andFood chemistry: X · 2022
    Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Tina SartoriusBioTeSys GmbH, Schelztorstr. 54-56, 73728 Esslingen, Germany.
Andrea WeidnerBioTeSys GmbH, Schelztorstr. 54-56, 73728 Esslingen, Germany.
Tanita DharsonoBioTeSys GmbH, Schelztorstr. 54-56, 73728 Esslingen, Germany.
Audrey BoulierIngredia S.A., 51 Avenue F. Lobbedez CS 60946, 62033 Arras CEDEX, France.
Manfred WilhelmDepartment of Mathematics, Natural and Economic Sciences, Ulm University of Applied Sciences, Albert-Einstein-Allee 55, 89081 Ulm, Germany.
Christiane SchönBioTeSys GmbH, Schelztorstr. 54-56, 73728 Esslingen, Germany. c.schoen@biotesys.de.
BioTeSys (Germany) · DEIngredia (France) · FRTechnische Hochschule Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Milk proteins have been hypothesized to protect against type 2 diabetes (T2DM) by beneficially modulating glycemic response, predominantly in the postprandial status. This potential is, amongst others, attributed to the high content of whey proteins, which are commonly a product of cheese production. However, native whey has received substantial attention due to its higher leucine content, and its postprandial glycemic effect has not been assessed thus far in prediabetes. In the present study, the impact of a milk protein hydrolysate of native whey origin with alpha-glucosidase inhibiting properties was determined in prediabetics in a randomized, cross-over trial. Subjects received a single dose of placebo or low- or high-dosed milk protein hydrolysate prior to a challenge meal high in carbohydrates. Concentration-time curves of glucose and insulin were assessed. Incremental areas under the curve (iAUC) of glucose as the primary outcome were significantly reduced by low-dosed milk peptides compared to placebo (

Indexed as

Dietary SupplementsPostprandial PeriodAdultAgedBiomarkersBlood GlucoseCross-Over StudiesDouble-Blind MethodFemaleGermanyGlycated HemoglobinGlycoside Hydrolase InhibitorsHumansInsulinMaleMiddle AgedBiomarkersBlood GlucoseGlycated HemoglobinGlycoside Hydrolase Inhibitorshemoglobin A1c protein, humanInsulinMilk ProteinsProtein Hydrolysatesalpha-glucosidase inhibitorbiopeptidesblood glucoseglycemic controlhyperglycemiamilk peptidespostprandialprediabetespre-mealtype 2 diabetes

Identifiers

PMID31340611
PMCPMC6683050
OpenAlexW2963285274

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.